首页> 外文会议>Trends in Radiopharmaceuticals(ISTR-2005) >A convenient synthetic procedure yielding 2-picolinamino-N,Ndiaceticacid monoamide derivatives, for labelling with the fac-M(CO)3+ core
【24h】

A convenient synthetic procedure yielding 2-picolinamino-N,Ndiaceticacid monoamide derivatives, for labelling with the fac-M(CO)3+ core

机译:一种方便的合成方法,可生成2-吡啶甲酸氨基-N,N-醋二乙酸单酰胺衍生物,用于用fac-M(CO)3+核标记

获取原文
获取原文并翻译 | 示例

摘要

In this study, an one step synthetic procedure was developed allowing the formation ofrntridentate ligands that are monoamido derivatives of picollimamino-N,N-diacetic acid (PADA)rnmolecule which binds efficiently with Re/Tc tricarbonyl core. This method simplifies to some extentrnthe incorporation of a biological active molecule which contains an amine group to the NNO donorrnatom system of PADA ligand providing thus an easy way for labelling a pharmacophore moiety withrntechnetium or rhenium. The synthetic scheme includes the preparation of the anhydride of PADA, 2.rnIts subsequent reaction with pyrolidine, aniline or 2-methoxyphenylpiperazine (a fragment of the truern5-HT1A antagonist WAY-100635) lead to the formation of corresponding NNO tridentate ligands, o-rn(C5H4N)CH2N(CH2COOH)CH2CON(CH2CH2)2 3a, o-(C5H4N)CH2N(CH2COOH)CH2CONHC6H5),rn3b, or o-(C5H4N)CH2N(CH2COOH)CH2CON(CH2CH2)2N(o-CH3OC6H4), 3c. All ligands were reactedrnsuccessfully with the fac-M(CO)3 cores (M = Re/99mTc). The rhenium complexes, Re(CO)3(NNO), 4acrnwere prepared by ligand exchange reactions using [Et4N][Re(CO)3Br3] as precursor. All complexesrnwere characterized by elemental analysis and spectroscopic methods. Complex 4a was furtherrncharacterized by X-ray crystallography. The in vitro affinity for the 5-HT1A receptors of the rheniumrncomplex 4c is in the nanomolar range (IC50 = 2 ± 0.3 nM). The analogues Tc-99m complexes,rn99mTc(CO)3(NNO) 5a-c, were prepared by ligand exchange reactions using [99mTc(CO)3(H2O)3]+ asrnprecursor. The identity of the 99mTc complexes was established by comparative HPLC analysis usingrnthe well characterized rhenium 4a-c complexes as reference. For biodistribution studies, the 5a and 5crncomplexes were administered in Swiss Albino mice. None of the new tracer agents showed significantrnbrain uptake. Both complexes exhibits rapid blood clearance and elimination mainly through thernhepatobiliary system.
机译:在这项研究中,开发了一步合成方法,该方法允许形成三齿配体,该三齿配体是皮氨基氨基-N,N-二乙酸(PADA)分子的单酰胺衍生物,可与Re / Tc三羰基核心有效结合。该方法在某种程度上简化了将含有胺基的生物活性分子掺入PADA配体的NNO供体原子体系中,从而为用tech或or标记药效团部分提供了简便的方法。合成方案包括制备PADA的酸酐2.n。其随后与吡咯烷,苯胺或2-甲氧基苯基哌嗪(truern5-HT1A拮抗剂WAY-100635的片段)反应,导致形成相应的NNO三齿配体,o- rn(C5H4N)CH2N(CH2COOH)CH2CON(CH2CH2)2 3a,邻-(C5H4N)CH2N(CH2COOH)CH2CONHC6H5),rn3b或邻-(C5H4N)CH2N(CH2COOH)CH2CON(CH2CH2)2NH(o-CH2) 3c。所有配体均与fac-M(CO)3核心成功反应(M = Re / 99mTc)。以[Et4N] [Re(CO)3Br3]为前体,通过配体交换反应制备了Re配合物Re(CO)3(NNO)4acrn。所有配合物均通过元素分析和光谱学方法表征。配合物4a通过X射线晶体学进一步表征。对the复合物4c的5-HT1A受体的体外亲和力在纳摩尔范围内(IC50 = 2±0.3 nM)。使用[99mTc(CO)3(H2O)3] +前体通过配体交换反应制备类似物Tc-99m复合物rn99mTc(CO)3(NNO)5a-c。 99mTc配合物的鉴定通过比较HPLC分析,以特征明确的characterized4a-c配合物为参考。为了进行生物分布研究,在瑞士白化病小鼠中施用了5a和5crn复合物。没有一种新的示踪剂显示出显着的脑摄取。两种复合物主要通过肝胆系统表现出快速的血液清除和清除。

著录项

  • 来源
  • 会议地点 Vienna(AT)
  • 作者单位

    Department of Pharmaceutical Chemistry, School of Pharmacy,rnAristotle University of Thessaloniki,rnThessaloniki 54124, Greece;

    rnInstitute of Radioisotopes and Radiodiagnostic Products,NCSR "Demokritos",rnAg.Paraskevi Attikis15310, Greece;

    Institute of Biology,rnNCSR "Demokritos",rnAg.Paraskevi Attikis15310, Greece;

    Institute of Radioisotopes and Radiodiagnostic Products,NCSR "Demokritos",rnAg.Paraskevi Attikis15310, Greece;

    Institute of Radioisotopes and Radiodiagnostic Products,NCSR "Demokritos",rnAg.Paraskevi Attikis15310, Greece;

    Institute of Radioisotopes and Radiodiagnostic Products,NCSR "Demokritos",rnAg.Paraskevi Attikis15310, Greece;

    Department of Pharmaceutical Chemistry, School of Pharmacy,rnAristotle University of Thessaloniki,rnThessaloniki 54124, Greece;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 放射医学;
  • 关键词

  • 入库时间 2022-08-26 14:06:33

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号